Acute hemodynamic effects terazosin hypertensive normotensive patients Terazosin selective alpha antagonist patients undergoing cardiac catheterization short-term hemodynamic effects Hemodynamic measurements minutes doses drug milligram terazosin blood pressure systolic/diastolic mean mean mm Hg mm Hg patients mg drug blood pressure dose-dependent manner mm Hg mg mm Hg mg drug changes blood pressure terazosin-induced decrease systemic resistance Similar changes pulmonary artery capillary wedge pressures pulmonary vascular resistance hemodynamic response first drug dose doses diminished incremental effect Cardiac output heart rate maximum ventricular dp/dt little change ventricular end-diastolic pressure doses significance mg mm Hg ventricular ejection fraction mg dose dependence analogous systemic resistance statistical significance indexes aortic stiffness compliance favorable effect data consistent terazosin specific alpha Left ventricular performance afterload reduction terazosin direct effect cardiac contractility 